| Norah Dee, MA, CCC-SLP | |
|
6500 Oak St, Arvada, CO 80004-2730 | |
| (303) 982-2775 | |
| Not Available |
| Full Name | Norah Dee |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 6500 Oak St, Arvada, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881462109 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 12068198 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Norah Dee, MA, CCC-SLP 8045 Holland Ct Apt B, Arvada, CO 80005-2284 Ph: (720) 280-1449 | Norah Dee, MA, CCC-SLP 6500 Oak St, Arvada, CO 80004-2730 Ph: (303) 982-2775 |
News Archive
The National Comprehensive Cancer Network announces the availability of the NCCN Reimbursement Resource App, a free resource through which patients with cancer, providers, case managers, and payers can search for available reimbursement resources and patient assistance programs for multiple cancer types and supportive care indications.
One of the reasons coronary heart disease is so deadly is that fluid build-up and scarring can develop in the heart tissue. This prevents the heart from contracting properly, impacting its ability to supply the body with fresh blood. If scarring is extensive, heart failure can result.
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that pretargeted therapy with TF2, a bispecific antibody against carcinoembryonic antigen (CEA) and a small peptide, delayed tumor growth and prolonged survival in an animal model of human colonic cancer.
The PATH Malaria Vaccine Initiative (MVI) today announced a new collaboration to initiate development toward a vaccine that may eventually help eliminate and eradicate malaria. This collaboration with the Johns Hopkins Bloomberg School of Public Health (JHSPH) and the Sabin Vaccine Institute (Sabin) marks MVI's first investment in transmission-blocking vaccines (TBVs). This vaccine approach aims to stop the malaria parasite from developing in the mosquito, effectively blocking transmission of malaria from mosquitoes to humans. Malaria kills nearly 900,000 people per year, most of them children younger than age five.
› Verified 3 days ago
Kay, Lynn Swanson, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7015 Nile Ct, Arvada, CO 80007 Phone: 303-503-3742 | |
Serena Laughren, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 9713 W 57th Pl, Arvada, CO 80002 Phone: 720-722-0411 | |
Caitlin Page, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6616 Reed Ct, Arvada, CO 80003 Phone: 720-434-7777 | |
Mrs. Lisa Moore, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9353 Iron Mountain Way, Arvada, CO 80007 Phone: 937-313-5347 | |
Clg Solutions Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9090 Flora St, Arvada, CO 80005 Phone: 720-435-0350 | |
Speech Garden Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9713 W 57th Pl, Arvada, CO 80002 Phone: 720-722-0411 | |
Carly Melissa Murray, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8448 Otis Dr, Arvada, CO 80003 Phone: 303-570-3181 |